UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended
December 31, 2021
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report _________
Commission file number: 000-30324
RADWARE LTD.
(Exact name of registrant as specified in its charter)
Israel
(Jurisdiction of incorporation or organization)
22 Raoul Wallenberg Street, Tel Aviv 6971917, Israel
(Address of principal executive offices)
Guy Avidan
Chief Financial Officer
Tel. +972-3-7668666, Fax: +972-3-7668982
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Ordinary Shares, NIS 0.05 par value per share
RDWR
The Nasdaq Stock Market LLC
Securities registered or to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period
covered by the annual report (December 31, 2021):
45,871,957 Ordinary Shares, NIS 0.05 par value per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
☒ Yes ☐ No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
☐ Yes ☒ No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer ☒
Accelerated Filer ☐
Non-Accelerated Filer ☐
Emerging growth company ☐
-2-
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
☒
U.S. GAAP
☐
International Financial Reporting Standards as issued by the International Accounting Standards Board
Other
If “Other” has been checked in response to the previous question indicate by check mark which financial statement item the registrant has elected to follow:
☐ Item 17 ☐ Item 18
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
-3-
RADWARE LTD. AND ITS SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2021
U.S. DOLLARS IN THOUSANDS
INDEX
Page
Reports of Independent Registered Public Accounting Firm
F-2 - F-4
(PCAOB ID:1281)
Consolidated Balance Sheets
F-5 - F-6
Consolidated Statements of Income
F-7
Consolidated Statements of Comprehensive Income
F-8
Statements of Changes in Shareholders' Equity
F-9
Consolidated Statements of Cash Flows
F-10 - F-11
Notes to Consolidated Financial Statements
F-12 - F-48
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of Radware Ltd.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Radware Ltd. and its subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, changes in shareholders' equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated April 11, 2022, expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
F - 2
Revenue Recognition – establishment of standalone selling prices
Description of the Matter
As described in Note 2 to the consolidated financial statements, some of the Company’s contracts with customers consist of several goods and services such as products, services and subscriptions, which are accounted for as separate performance obligations when they are distinct. In such cases, the transaction price is then allocated to the distinct performance obligations on a relative standalone selling price basis and recognizes associated revenue as control is transferred to the customer.
Auditing the estimate of standalone selling price for performance obligation not sold separately involved subjective auditor judgment due to the absence of directly observable data which requires the Company to make subjective assumptions used to estimate the standalone selling price for each performance obligation. Standalone selling price for goods and services can evolve over time due to changes in the Company’s pricing practices that are influenced by intense competition, changes in demand for products and services, and economic factors, among others. Given these factors, the related audit effort in evaluating management’s judgments in determining revenue recognition for these customer contracts was extensive and required subjective auditor judgment.
How We Addressed
the Matter in Our
Audit
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls relating to the revenue recognition process, including the estimate of standalone selling prices for each distinct performance obligation and review of assumptions used.
Our audit procedures included testing management's estimate of standalone selling price for each distinct performance obligation included, among others, evaluating the appropriateness of the methodology applied and the reasonableness of management’s judgment and assumptions by comparing these assumptions with prior years and with entity and industry’s general and specific trends. We also inspected the source of historical data, pricing and other observable inputs such as customer grouping, tested the mathematical accuracy of the underlying data and evaluated the accounting policies and practices related to the estimate of standalone selling prices by management. In addition, we have tested the accuracy of management’s allocation of the transaction price to the performance obligations contained within sampled contracts and purchase orders with customers and evaluated whether revenue was recognized in the appropriate amounts and period. We also evaluated and tested the Company’s disclosures included in Note 2 to the consolidated financial statements.
/s/ KOST FORER GABBAY & KASIERER
A Member of Ernst & Young Global
We have served as the Company's auditor since 2002.
Tel-Aviv, Israel
April 11, 2022
F - 3
Opinion on Internal Control over Financial Reporting
We have audited Radware Ltd. and its subsidiaries' internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Radware Ltd. and its subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income, changes in shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and our report dated April 11, 2022 expressed an unqualified opinion thereon.
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
F - 4
CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands
December 31,
2021
2020
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
$
92,513
54,771
Marketable securities
39,497
64,684
Short-term bank deposits
155,879
191,038
Trade receivables, net of allowance for credit losses of $174 and $183 at December 31, 2021 and 2020, respectively
13,191
16,848
Other current assets and prepaid expenses
8,046
6,526
Inventories
11,580
13,935
Total current assets
320,706
347,802
LONG-TERM INVESTMENTS:
98,224
66,836
Long-term bank deposits
79,708
71,421
Other assets
2,454
2,453
Total long-term investments
180,386
140,710
Property and equipment, net
20,240
22,976
Operating lease right-of-use assets
24,829
27,823
Intangible assets, net
10,731
12,588
Goodwill
41,144
Other long-term assets
37,334
30,222
Total assets
635,370
623,265
The accompanying notes are an integral part of the consolidated financial statements.
F - 5
U.S. dollars in thousands, except share and per share data
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Trade payables
4,310
3,882
Deferred revenues
99,922
92,127
Operating lease liabilities
5,090
5,224
Employees and payroll accruals
26,284
27,007
Other payables and accrued expenses
30,281
15,507
Total current liabilities
165,887
143,747
LONG-TERM LIABILITIES:
67,065
54,797
22,360
24,851
Other long-term liabilities
10,065
11,409
Total long-term liabilities
99,490
91,057
COMMITMENTS AND CONTINGENT LIABILITIES
SHAREHOLDERS' EQUITY:
Share capital -
Ordinary shares of NIS 0.05 par value - Authorized: 90,000,000 at December 31, 2021 and 2020; Issued: 60,641,047 and 59,284,860 shares at December 31, 2021 and 2020, respectively; Outstanding: 45,871,957 and 46,386,889 shares at December 31, 2021 and 2020, respectively
730
721
Additional paid-in capital
471,173
443,018
Treasury stock 14,769,090 and 12,897,971 of ordinary shares at December 31, 2021 and 2020, respectively
(243,023
)
(190,552
Accumulated other comprehensive income (loss)
(455
1,517
Retained earnings
141,568
133,757
Total shareholders' equity
369,993
388,461
Total liabilities and shareholders' equity
F - 6
CONSOLIDATED STATEMENTS OF INCOME
U.S. dollars in thousands, except share data
Year ended
2019
Revenues:
Products
170,438
132,934
133,605
Services
116,058
117,093
118,467
Total revenues
286,496
250,027
252,072
Cost of revenues:
42,191
34,645
35,056
10,255
10,439
10,118
Total cost of revenues
52,446
45,084
45,174
Gross profit
234,050
204,943
206,898
Operating expenses, net:
Research and development, net
74,098
61,841
Sales and marketing
119,842
113,015
109,556
General and administrative
21,885
18,924
18,584
Total operating expenses, net
215,825
198,775
189,981
Operating income
18,225
6,168
16,917
Financial income, net
4,407
7,796
8,792
Income before taxes on income
22,632
13,964
25,709
Taxes on income
14,821
4,328
3,143
Net income
7,811
9,636
22,566
Basic net earnings per share
0.17
0.21
0.48
Diluted net earnings per share
0.16
0.20
0.47
Weighted average shares used to compute net income per share:
Basic
45,919,835
46,460,974
46,816,899
Diluted
47,503,091
47,739,540
48,523,120
F - 7
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Other comprehensive income (loss) before tax:
Unrealized gains (losses) on marketable securities:
Changes in unrealized gains (losses)
(2,999
339
2,928
Less: reclassification adjustments for gains included in net income
(438
(144
-
Other comprehensive income (loss) before tax
(2,561
483
Income tax benefits (income tax expenses) related to components of other comprehensive income (loss)
589
(111
(673
Other comprehensive income (loss), net of tax
(1,972
372
2,255
Comprehensive income
5,839
10,008
24,821
F - 8
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
Number of outstanding ordinary shares
Share Capital
Treasury stock, at cost
Total
Balance as of January 1, 2019
46,347,403
693
383,536
(120,717
(1,110
101,555
363,957
Repurchase of ordinary shares
(998,399
(24,509
Issuance of shares upon exercise of share options and vesting of restricted shares units
1,638,753
17
17,981
17,998
Share based compensation
13,064
Other comprehensive income, net of tax
Balance as of December 31, 2019
46,987,757
710
414,581
(145,226
1,145
124,121
395,331
(1,953,960
(45,326
1,353,092
11
11,892
11,903
16,545
Balance as of December 31, 2020
46,386,889
(1,871,119
(52,471
1,356,187
9
10,581
10,590
17,574
Other comprehensive loss, net of tax
Balance as of December 31, 2021
45,871,957
F - 9
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended December 31,
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
10,196
10,559
11,283
Stock based compensation
Gain on sale of marketable securities
(639
(537
Amortization of premiums, accretion of discounts and accrued interest on marketable securities, net
2,720
931
618
Accrued interest on bank deposits
2,424
(1,210
2,123
Increase in accrued severance pay, net
468
202
888
Decrease (increase) in trade receivables, net
3,657
5,762
(2,407
Changes in deferred income taxes, net
(3,466
333
(1,535
Increase in other current assets and prepaid expenses
(4,625
(5,217
(5,454
Decrease in inventories
2,355
5
4,461
Increase (decrease) in trade payables
428
(2,433
1,775
Increase in deferred revenues
20,063
16,797
2,260
Increase in other payables and accrued expenses
12,238
11,305
2,784
5,532
5,593
5,962
(5,163
(4,304
(4,999
Net cash provided by operating activities
71,774
63,865
52,852
Cash flows from investing activities:
Purchase of property and equipment
(5,603
(8,671
(8,155
Proceeds from (investing in) other long-term assets
49
(110
4
Proceeds from (investing in) bank deposits
24,448
(23,878
15,960
Purchase of marketable securities
(88,300
(32,981
(67,145
Proceeds from maturity of marketable securities
59,980
29,452
17,005
Proceeds from sale of marketable securities
17,275
21,820
3,777
Payment for the acquisition of subsidiary, net of cash acquired
(12,239
Net cash provided by (used in) investing activities
7,849
(14,368
(50,793
F - 10
Cash flows from financing activities:
Proceeds from exercise of share options
Payment of deferred consideration related to acquisition
(2,054
Net cash used in financing activities
(41,881
(35,477
(6,511
Increase (decrease) in cash and cash equivalents
37,742
14,020
(4,452
Cash and cash equivalents at the beginning of the year
40,751
45,203
Cash and cash equivalents at the end of the year
Supplemental disclosure of cash flow information:
Cash paid during the year for taxes on income
2,748
1,314
3,296
Non-cash investing activities:
Right-of-use assets recognized with corresponding lease liabilities
2,538
15,272
24,105
Deferred consideration related to acquisition
2,080
F - 11
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1:- GENERAL
a.Radware Ltd. (the "Company"), an Israeli company commenced operations in April 1997. The Company and its subsidiaries (the "Group") are engaged in the development, manufacture and sale of cyber security and application delivery solutions for cloud, physical, and Software Defined Data Centers (“SDDC”). The Group’s solutions secure the digital experience by providing infrastructure, application, and corporate IT protection and availability services to enterprises globally. The Group’s solutions are deployed by, among others, enterprises, carriers and cloud service providers worldwide.
b.The Company has established wholly-owned subsidiaries in various countries worldwide. The Company's subsidiaries are engaged primarily in sales, marketing and support activities of its core products.
c.The Group primarily relies on two original design manufacturers to supply certain hardware platforms and components for the production of its products. If one of these suppliers fails to deliver or delays the delivery of the necessary components, the Group will be required to seek alternative sources of supply. A change in suppliers could result in manufacturing delays, which could cause a possible loss of sales and, consequently, could adversely affect the Company's operation and financial performance.
The Group depended on a sole single-managed security service provider, which is a related party, to provide services as part of its protection services. If the managed security service provider were to fail to provide or delay the delivery of the services, the Group would be required to seek alternative sources of the services. A change in its managed security service provider could result in a possible loss of sales and, consequently, could adversely affect the Group’s operation and financial performance (see Note 17). However, on February 17, 2022, the Company acquired all of the technology and other intangible assets from the managed security service provider (see Note 18).
F - 12
NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES
The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”).
a.Use of estimates:
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The coronavirus (“COVID-19”) pandemic has created, and may continue to create, significant uncertainty in macroeconomic conditions, and the extent of its impact on the Company’s operational and financial performance will depend on certain developments, including the duration and spread of the outbreak and the impact on the Company’s customers and its sales cycles. The Company considered the impact of COVID-19 on the estimates and assumptions and determined that there were no material adverse impacts on the consolidated financial statements for the year ended December 31, 2021. As events continue to evolve and additional information becomes available, the Company’s estimates and assumptions may change materially in future periods.
b.Financial statements in United States dollars:
A majority of the Group’s revenues are denominated in United States dollars (“dollar” or “U.S. dollars”). In addition, a substantial portion of the Company’s and certain of its subsidiaries’ costs are denominated in dollar. The Company’s management believes that the dollar is the primary currency of the economic environment in which the Group operates. Thus, the functional and reporting currency of the Group is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are re-measured into dollars in accordance with Accounting Standards Codification (“ASC”) No. 830 “Foreign Currency Matters”. All transaction gains and losses from the re-measured monetary balance sheet items are reflected in the consolidated statements of income as financial income or expenses, as appropriate.
c.Principles of consolidation:
The consolidated financial statements include the accounts of the Group. All intercompany transactions and balances have been eliminated upon consolidation.
d.Cash equivalents:
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at acquisition.
F - 13
NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (Cont.)
e.Bank deposits:
Bank deposits with maturities of more than three months but less than one year are included in short-term bank deposits. Such short-term bank deposits are stated at cost which approximate market values.
Bank deposits with maturities of more than one year are included in long-term bank deposits. Long-term bank deposits are stated at cost which approximates market values.
f.Investment in marketable securities:
The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments - Debt and Equity Securities”. Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date.
The Company classifies its marketable securities as either short-term or long-term based on each instrument’s underlying contractual maturity date and the entity’s expectations of sales and redemptions in the following year.
The Company classified all of its securities as available-for-sale marketable securities. Debt securities are carried at fair value, with the unrealized gains and losses reported in “Accumulated other comprehensive income (loss)” in shareholders’ equity. Realized gains and losses on sales of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities.
The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities are included in financial income, net in the Company’s consolidated statements of income.
In 2020 the Company adopted Accounting Standard Update (“ASU”) 2016-13, Topic 326 “Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments” which modified the other than temporary impairment model for available-for-sale debt securities. Available-for-sale securities are periodically evaluated for unrealized losses. For unrealized losses in securities that the Company intends to hold and will not more likely than not be required to sell before recovery, the Company further evaluates whether declines in fair value below amortized cost are due to credit or non-credit related factors. The Company considers credit related impairments to be changes in value that are driven by a change in the creditor’s ability to meet its payment obligations and records an allowance and recognizes a corresponding loss in financial income, net when the impairment is incurred. Unrealized non-credit related losses and unrealized gains, net of tax, are reported as a separate component of accumulated other comprehensive income (loss) in the consolidated balance sheets until realized.
F - 14
The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in financial income, net. Credit loss impairments for the years ended December 31, 2021, and 2020 were immaterial.
Prior to January 1, 2020, the Company recognizes an impairment charge when a decline in the fair value of its investments below the cost basis is judged to be other-than-temporary. The factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company’s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. For securities that are deemed other-than-temporarily impaired, the amount of impairment recognized in the consolidated statements of income is limited to the amount related to credit losses, while impairment related to other factors is recognized in other comprehensive income. During 2019, the Company did not record other-than-temporary impairment loss (“OTTI”) with respect to its available-for-sale marketable securities.
g.Inventories:
Inventories are stated at the lower of cost or net realizable value. Inventory write-off is provided to cover risks arising from slow-moving items, technological obsolescence, excess inventories and discontinued products. Inventory write-offs totaled $2,028, $616 and $3,267 in 2021, 2020 and 2019, respectively, and have been included in cost of revenues of products in the Company’s consolidated statements of income.
Cost is determined as follows:
Raw materials and components - using the “first-in, first-out” method.
Work-in-progress and finished products - raw materials as above with the addition of subcontracting costs - calculated on the basis of direct subcontractors costs and with direct overhead costs.
The Company assesses the carrying value of its inventory for each reporting period to ensure inventory is reported at the lower of cost or net realizable value in accordance with ASC No. 330-10-35, “Inventory”. Charges for obsolete and slow-moving inventories are recorded based upon an analysis of specific identification of obsolete inventory items and quantification of slow-moving inventory items. These assessments consider various factors, including historical usage rate, technological obsolescence, estimated current and future market values and new product introduction. In cases when there is evidence that the anticipated utility of goods, in their disposal in the ordinary course of business, will be less than the historical cost of the inventory, the Company recognizes the difference as a current period charge to earnings and carries the inventory at the reduced cost basis until it is sold or disposed of.
F - 15
h.Property and equipment, net:
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
%
Computers, peripheral equipment and software
15 - 33 (mainly 33)
Office furniture and equipment
6 - 20 (mainly 15)
Leasehold improvements
Over the shorter of the term of
the lease or the useful life of the asset
i.Impairment of long-lived assets and intangible assets subject to amortization:
Property and equipment, right-of-use asset for leases and intangible assets subject to depreciation and amortization are reviewed for impairment in accordance with ASC No. 360, “Accounting for the Impairment or Disposal of Long-Lived Assets,” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.
Intangible assets acquired in a business combination are recorded at fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 7 to 9 years. Some of the acquired customer arrangements are amortized over their estimated useful lives in proportion to the economic benefits realized. This accounting policy results in accelerated amortization of such customer arrangements as compared to the straight-line method. All other intangible assets are amortized over their estimated useful lives on a straight-line basis. During 2021, 2020 and 2019, no impairment losses were recorded.
j.Goodwill:
Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC No. 350 “Intangibles – Goodwill and Other” (“ASC 350”), goodwill is not amortized, but rather is subject to an annual impairment test. ASC 350 requires goodwill to be tested for impairment at least annually or between annual tests in certain circumstances and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value.
F - 16
ASC 350 allows a company to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If the Company elects not to use this option, or if the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company prepares a quantitative analysis to determine whether the carrying value of a reporting unit exceeds its estimated fair value. If the carrying value of a reporting unit exceeds its estimated fair value, the Company recognizes an impairment of goodwill for the amount of this excess.
The Company operates in one operating segment, and this segment comprises its single reporting unit. The Company conducts its annual test of impairment for goodwill on December 31st of each year, or more frequently if impairment indicators are present. No impairment was recorded during 2021, 2020 and 2019.
k.Leases:
The Company accounts for its leases according to ASC 842 - Leases (“ASC 842”). The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability and a right-of-use (“ROU”) asset for leases with a term of twelve months or less.
ROU assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured based on the discounted present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. The implicit rate within the operating leases is generally not determinable, therefore the Company uses the Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset is located.
An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate the lease is considered unless it is reasonably certain that the Company will not exercise the option.
F - 17
l.Contingencies
The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss (see Note 11).
m.Revenue recognition:
The Group’s revenues are derived from sales of its products, services and subscriptions:
•
Revenues from physical products and software-based products are recognized when control of the promised goods is transferred to the customer, either upon shipment or when the product is delivered, depending on the commercial terms of each transaction. Revenues from product subscriptions and cloud subscriptions, included as product revenues, are recognized ratably, on a straight-line basis, over the subscription period.
Revenues from post-contract customer support (“PCS”), which represent mainly, help-desk support and unit repairs or replacements, professional services, and emergency response team (“ERT”) services are recognized ratably, on a straight-line basis, over the term of the related contract, which is typically between one year and three years. Renewals of support contracts create new performance obligations that are satisfied over the term with the revenues recognized ratably, on a straight-line basis, over the renewed period.
The Company’s solutions are sold primarily through distributors and resellers, all of which are considered end-users.
The Company recognizes revenues in accordance with ASC No. 606, “Revenue from Contracts with Customers”. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation.
The Company’s arrangements typically contain various combinations of its products, subscriptions and PCS, which are distinct and are accounted for as separate performance obligations. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price (“SSP”). If the SSP is not observable, the Company estimates the SSP taking into account available information such as geographic specific factors, customer grouping and internally approved historical pricing guidelines related to the performance obligation. For PCS, the Company determines the standalone selling price based on observable renewals prices. For subscriptions, the Company determines the standalone selling price based on standalone new subscription transactions and renewals.
F - 18
For products, the SSP is not observable, and therefore, the Company estimates the product SSP taking into account available information such as geographic specific factors, customer grouping and internally approved historical pricing guidelines.
Deferred revenues represent mainly the unrecognized revenue collected for subscriptions and for PCS. Such revenues are recognized ratably over the term of the related agreement. Out of the deferred revenues balance at the beginning of the year that ended December 31, 2021, approximately 64% was recognized as revenues during that year. Out of the deferred revenues balance at the beginning of the year that ended December 31, 2020, an amount of $110,544 was recognized as revenues during that year.
As of December 31, 2021, the aggregate amount of remaining performance obligations from contracts with customers was $281,565. The Company expects to recognize approximately 60% of its remaining performance obligations as revenue over the next twelve months, with the remaining recognized up to three years.
Remaining performance obligations represent the amount of the transaction price under contracts with customers that are attributable to performance obligations that are unsatisfied or partially satisfied at the reporting date. This consists of future committed revenue for monthly, quarterly or annual periods within current contracts with customers, as well as deferred revenue arising from consideration invoiced in prior periods for which the related performance obligations have not been satisfied.
The following table provides information about disaggregated revenues by major product line:
90,292
72,286
103,220
106,176
Subscriptions
92,984
71,565
For information regarding disaggregated revenues by geographical market, please see Note 15.
The balance of deferred revenues approximates the aggregate amount of the transaction price allocated to the remaining performance obligations at the end of reporting period. In general, the Company expects to recognize the long-term portion of deferred revenue mainly over the remaining service period of up to three years.
F - 19
The Company records a provision for estimated sale returns, credits and stock rotation granted to customers on products in the same period the related revenues are recorded. These estimates are based on historical sales returns, stock rotations and other known factors. Such provisions amounted to $2,494 and $2,739 as of December 31, 2021 and 2020, respectively. The provision for estimated sale returns, credits, and stock rotation as of December 31, 2021 and 2020, is included in other payables and accrued expenses in the consolidated balance sheets.
In instances of contracts where revenue recognition differs from the timing of invoicing, the Company generally determined that those contracts do not include a significant financing component. The primary purpose of the invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company’s products and services, not to receive or provide financing. The Company uses the practical expedient and does not assess the existence of a significant financing component when the difference between payment and revenue recognition is a year or less.
Costs to obtain contracts:
Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. Commission costs related to long-term service contracts and performance obligations satisfied over time are deferred and recognized on a systematic basis that is consistent with the transfer of the products or services to which the asset relates. Sales commissions paid for new contracts, which are not commensurate with sales commissions paid for renewal contracts, are capitalized and amortized over an expected period of benefit and are included in sales and marketing expenses in the accompanying consolidated statements of income. The Company applies judgment in estimating the amortization period, by taking into consideration its product life term, history of renewals, expected length of customer relationship, as well as the useful life of the underlying technology and products. As of December 31, 2021, the Company has determined the expected period of benefit to be approximately 3.37 years. Deferred commission costs capitalized are periodically reviewed for impairment.
As of December 31, 2021 and 2020, the amount of deferred commission was $23,940 and $20,867, respectively and is included in other long-term assets on the consolidated balance sheets.
During the year ended December 31, 2021 and 2020, the Company recorded amortization expenses in connection with deferred commissions in the amount of $10,091 and $9,902, respectively.
n.Shipping and handling fees and costs:
Shipping and handling fees charged to the Company’s customers are recognized as product revenue in the period shipped and the related costs for providing these services are recorded as a product cost of revenues in the consolidated statements of income.
F - 20
o.Cost of revenues:
Cost of products is comprised of cost of software and hardware production, manuals, packaging, license fees paid to third parties, fees paid to managed security service provider (related parties), inventory write-offs and amortization of acquired technology.
Cost of services is comprised of cost of post-sale customer support and hosting services.
p.Warranty costs:
The Company generally provides a one year warranty for all of its products. A provision is recorded for estimated warranty costs at the time revenues are recognized based on the Company’s historical experience. Warranty expenses for the years ended December 31, 2021, 2020 and 2019 were immaterial.
q.Research and development expenses, net:
Research and development costs are charged to the consolidated statements of income as incurred. ASC No. 985-20, “Software - Costs of Software to Be Sold, Leased, or Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.
Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred.
r.Government grants:
During 2019-2021, the Company received non-royalty-bearing grants from the Israel Innovation Authority (“IIA”) for approved research and development projects. These grants are recognized at the time the Company is entitled to such grants on the basis of the costs incurred as provided by the relevant agreement and included as a deduction from research and development expenses, net.
Research and development grants deducted from research and development expenses, net amounted to $962, $924 and $937 for the years ended December 31, 2021, 2020 and 2019, respectively.
In addition, during 2021, an Israeli subsidiary of the Company received royalty-bearing grants from the IIA for approved research and development projects. These grants are recognized at the time the Israeli subsidiary is entitled to such grants on the basis of the costs incurred as provided by the relevant agreement and included as a deduction from research and development expenses, net.
F - 21
Per the agreement with the IIA, and pursuant to applicable laws, the Israeli subsidiary is required to pay royalties at the rate of 3% of sales of products developed with funds provided by the IIA, up to an amount equal to 100% of the IIA research and development grants received. Grants amounted to $333 for the year ended December 31, 2021.
s.Accounting for share-based compensation:
The Company accounts for share-based compensation in accordance with ASC No. 718, “Compensation-Stock Compensation” (“ASC 718“). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s consolidated statements of income.
The Company recognizes compensation expenses for the value of its awards based on the accelerated attribution method over the requisite service period of each of the awards, net of estimated forfeitures. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Estimated forfeitures are based on actual historical pre-vesting forfeitures.
The Company selected the Black-Scholes-Merton option pricing model to account for the fair value of its share-options awards with only service conditions and whereas the fair value of the restricted share units awards (“RSUs”) is based on the market value of the underlying shares at the date of grant.
Compensation expense related to the market-condition based RSUs granted to the Chief Executive Officer of the Company is computed using the fair value of the awards at the date of grant. Potential shares to be issued for market-condition share awards granted in 2020 and 2019 are subject to a market condition based on the price of the Company’s ordinary share. The fair value of these awards was determined using a Monte Carlo simulation methodology.
The fair value of each market-condition based RSUs is estimated on the date of grant using the Monte Carlo model that uses the assumptions noted in the following table:
Risk free interest rate
0.36%
1.59%
Dividend yields
0%
Expected volatility
24.97%
27.67%
The option-pricing models require a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical share price movements over an historical period equivalent to the option’s expected term.
F - 22
The expected option term represents the period of time that options are expected to be outstanding based on historical experience. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.
The fair value of the Company’s share options granted to employees and directors for the years ended December 31, 2021, 2020 and 2019 was estimated using the following weighted average assumptions:
Employees’ share option plan:
0.89%
0.33%
1.86%
27%
26%
Weighted average expected term from grant date (in years)
3.46
3.68
3.83
t.Income taxes:
The Company accounts for income taxes in accordance with ASC No. 740, “Income Taxes” (“ASC 740”). This statement prescribes the use of the liability method whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized.
ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes.
The second step is only addressed if the first step has been satisfied (i.e. the position is more likely than not to be sustained) otherwise a full liability in respect of a tax position not meeting the more likely than not criteria is recognized.
The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalty, if any related to unrecognized tax benefits in its taxes on income in the consolidated statements of income.
F - 23
u.Concentrations of credit risks:
Financial instruments that potentially subject the Group to concentrations of credit risk consist principally of cash and cash equivalents, bank deposits, marketable securities and trade receivables.
The majority of the Group’s cash, cash equivalents and bank deposits are invested in major banks in Israel and the U.S. The Israeli bank deposits are not insured, while the deposits made in the United States are in excess of insured limits and are not otherwise insured. Generally, these cash equivalents may be redeemed upon demand and, therefore management believes that it bears a lower risk. The short-term and long-term bank deposits are held in financial institutions which management believes are institutions with high credit standing, and accordingly, minimal credit risk from geographic or credit concentration exists with respect to these bank deposits. As of December 31, 2021, 6%, 42%, and 31% of the Company’s short and long-term bank deposits were deposited in major Israeli banks in Israel which are rated A, AAA and BBB+, respectively, as determined by the Israeli affiliate of Standard & Poor’s (“S&P”), and 21% were deposited in the U.S. branch of another major Israeli bank which is also rated A, as determined by the Israeli affiliate of S&P.
As of December 31, 2021, the maximal contractual duration of any of the Company’s bank deposits was 2 years, the weighted average duration of the Company’s deposits was 1.5 years, and the weighted average time to maturity was 0.8 years.
The Company’s marketable securities included investment in foreign banks, government debentures and corporate debentures. The financial institutions that hold the Company’s marketable securities are major U.S. financial institutions, located in the United States. The Company’s management believes that the Company’s marketable securities portfolio is a diverse portfolio of highly-rated securities and the Company’s investment policy limits the amount the Company’s may invest in each issuer, and accordingly, management believes that minimal credit risk exists from geographic or credit concentration with respect to these securities.
From geographic prospective, 53% of the Company’s debt marketable securities portfolio was invested in debt securities of U.S. issuers, 7% was invested in debt securities of European issuers and 40% was invested in debt securities of other geographic-located issuers. As of December 31, 2021, 92% of the Company’s debt marketable securities portfolio was rated A- or higher, as determined by S&P and 8% was rated BBB or BBB+.
The trade receivables of the Group are mainly derived from sales to customers located primarily in the United States, Europe, the Middle East, Africa and Asia Pacific. The Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions and other factors that may affect its ability to collect from customers.
The estimated credit loss allowance is recorded as general and administrative expenses on the Company’s consolidated statements of income. In certain circumstances, the Company may require from its customers letters of credit, other collateral or additional guarantees.
For the year ended December 2021, 2020 and 2019 bad debt expenses were $18, $104 and nil. Total write-offs during 2021 and 2020 amounted to nil and in 2019 amounted to $154.
F - 24
v.Employee related benefits:
Severance pay:
Effective April 1, 2007, the Company’s agreements with employees in Israel, are under Section 14 of the Israeli Severance Pay Law, 1963. The Company’s contributions for severance pay have extinguished its severance obligation. Upon contribution of the full amount based on the employee’s monthly salary for each year of service, no additional obligation exists regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheets, as the Company is legally released from the obligation to pay severance amounts to employees once the required deposit amounts have been fully paid.
For the Company’s employees in Israel who are not subject to Section 14, the Company calculated the liability for severance pay pursuant to the Severance Pay Law based on the most recent salary of these employees multiplied by the number of years of employment as of the balance sheet date. The Company’s liability for these employees is fully provided for via monthly deposits with severance pay funds, insurance policies and accruals. The value of these deposits recorded as an asset on the Company’s balance sheet under other assets. The amount of accrued severance payable recorded as a liability on the Company’s balance sheet under other long-term liabilities as of December 31, 2021 and 2020 is $2,454 and $2,453, respectively.
Severance pay expenses for the years ended December 31, 2021, 2020 and 2019 amounted to approximately $5,455, $4,800 and $4,066, respectively. Accrued severance pay is included in other long-term liabilities in the consolidated balance sheets.
w.Fair value of financial instruments:
The Company measures its cash equivalents, bank deposits and marketable securities at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
Level 1 -Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 -Include other inputs that are directly or indirectly observable in the marketplace.
Level 3 -Unobservable inputs which are supported by little or no market activity.
F - 25
The carrying amounts of cash equivalents, trade receivables, trade payables, short-term bank deposits, other current assets and prepaid expenses and other payables and accrued expenses, approximate at fair value because of their generally short maturities.
x.Comprehensive income (loss):
The Company accounts for comprehensive income (loss) in accordance with ASC No. 220, “Comprehensive Income.” This statement establishes standards for the reporting and display of comprehensive income (loss) and its components in a full set of general purpose financial statements. Comprehensive income (loss) generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its only item of other comprehensive income (loss) relates to available-for-sale debt marketable securities adjustment.
y.Treasury stock:
The Company repurchases its ordinary shares from time to time on the open market and holds such shares as treasury stock. The Company presents the cost to repurchase treasury stock as a reduction of shareholders’ equity. The voting rights attached to treasury stock are revoked.
z.Basic and diluted net income per share:
Basic net income per share is computed based on the weighted average number of ordinary shares outstanding during each period. Diluted net income per share is computed based on the weighted average number of ordinary shares outstanding during each period, plus potential dilutive ordinary shares considered outstanding during the period, if any, in accordance with ASC No. 260, “Earnings Per Share”. The total number of ordinary shares related to outstanding stock options excluded from the calculation of diluted income per share as they would have been anti-dilutive was 35,208, 916,440 and 1,938,808 for the years ended December 31, 2021, 2020 and 2019, respectively.
aa.Business combinations:
The Company accounted for business combination in accordance with ASC No. 805, “Business Combinations” (“ASC 805”).
ASC No. 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date.
The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred.
F - 26
Under ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business (“2017-01”), the Company first determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the single asset or group of assets, as applicable, is not a business.
NOTE 3:-ACQUISITIONS
On March 12, 2019 (the “Closing Date”), the Company completed the acquisition of all of the outstanding shares of Kaalbi Technologies Private Ltd. (“ShieldSquare”), a company engaged in Bot mitigation and Bot management solutions for a total consideration of $14,203 denominated in Indian Rupee, as determined in the agreement ($14,319 as of Closing Date). The total consideration was composed of (1) $12,558 in cash payable at closing (subject to certain working capital adjustments, $12,239 upon closing) and (2) $2,080 ($2,035 at December 31, 2019) deferred consideration to secure possible indemnity claims for damages arising out of breaches or inaccuracies of Shieldsquare’s or Shieldsquare shareholders’ representations, to be paid 18 months subsequent to the acquisition date. During 2020, the Company paid $2,054 with respect to the deferred consideration.
The acquisition was accounted for as a business combination and the purchase consideration was allocated to assets acquired and liabilities assumed based on their estimated fair values, as presented in the following table:
Consideration:
Cash consideration paid on closing date, including working capital adjustments
12,239
Deferred consideration
Total purchase price
14,319
Identifiable assets acquired, and liabilities assumed:
Technology
7,385
8,970
Other current assets
271
Deferred tax liability
(2,307
The estimated useful life of the technology is approximately 9 years.
The derived goodwill from this acquisition is attributable to additional capabilities of the Company to expand its products portfolio. Goodwill generated from this business combination is primarily attributable to synergies between the Company’s and Shieldsquare’s respective products and services. Pro forma results of operations for this acquisition have not been presented because they are not material to the consolidated statements of income.
F - 27
NOTE 4:-MARKETABLE SECURITIES
Debt securities with contractual maturities of less than one year are as follows:
Amortized
Gross unrealized
Market
cost
losses
gains
value
Foreign banks and government debentures
18,246
107
18,353
31,024
390
31,414
Corporate debentures
21,050
(5
99
21,144
32,964
306
33,270
Total marketable securities
39,296
206
63,988
696
Debt securities with contractual maturities from one to three years are as follows:
34,317
(304
46
34,059
28,200
(28
569
28,741
64,699
(649
115
64,165
37,362
(10
743
38,095
99,016
(953
161
65,562
(38
1,312
The Company does not have any debt securities with contractual maturities of more than three years as of December 31, 2021 and 2020.
Debt securities with continuous unrealized losses for less than 12 months and 12 months or greater and their related fair values as of December 31, 2021 are as follows:
Investments with continuous unrealized losses for less than 12 months
Investments with continuous unrealized losses for 12 months or greater
Total investments with continuous unrealized losses
Fair
Unrealized
Value
22,075
(202
10,491
(104
32,566
(306
49,526
(521
13,903
(132
63,429
(653
Total available-for-sale marketable securities
71,601
(723
24,394
(236
95,995
(959
Debt securities with continuous unrealized losses for less than 12 months and 12 months or greater and their related fair values as of December 31, 2020 were immaterial.
As of December 31, 2021, and 2020, interest receivable amounted to $994 and $1,103, respectively, and is included within marketable securities in the consolidated balance sheets.
F - 28
NOTE 5:-FAIR VALUE MEASUREMENTS
In accordance with ASC No. 820, “Fair Value Measurements and Disclosures”, the Company measures its cash equivalents, marketable securities and deferred consideration at fair value on recurring basis. Cash equivalents and marketable securities are classified within Level 1 or Level 2 since these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs.
The Company’s financial assets and liabilities measured at fair value on a recurring basis, including interest receivable components consisted of the following types of instruments as of December 31, 2021, and 2020:
Fair value measurements using input type
Level 1
Level 2
Level 3
Assets
Cash equivalents:
Money market funds
488
Marketable securities:
52,412
85,309
Total financial assets
137,721
138,209
December 31, 2020
6,999
60,155
71,365
131,520
138,519
F - 29
NOTE 6:-INVENTORIES
Inventories are comprised of the following:
Raw materials and components
2,028
1,859
Work-in-progress
729
1,151
Finished products
8,823
10,925
NOTE 7:-PROPERTY AND EQUIPMENT, NET
Cost:
Computer, peripheral equipment and software
103,291
100,516
13,489
13,126
7,493
7,425
124,273
121,067
Accumulated depreciation:
88,323
83,822
10,504
9,551
5,206
4,718
104,033
98,091
Depreciation expenses for the years ended December 31, 2021, 2020 and 2019 were $8,339, $8,666 and $8,912, respectively.
F - 30
NOTE 8:-INTANGIBLE ASSETS, NET
Intangible assets:
Weighted
average
amortization
period
(years)
Acquired technology
8.7
32,946
Customers relationships and brand name
5.8
9,817
42,763
Accumulated amortization:
22,215
20,358
32,032
30,175
Amortization expenses for the years ended December 31, 2021, 2020 and 2019 were $1,857, $1,893 and $2,371, respectively.
Future estimated amortization expenses for the years ending:
2022
1,857
2023
2024
2025
2026
1,615
2027 and thereafter
1,688
NOTE 9:-LEASES
The Company has various operating leases for office space, vehicles and warehouse space that expire on different dates through 2030. Its lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. The Company provided several security deposits mainly to secure various operating lease agreements in connection with its office space.
F - 31
NOTE 9:-LEASES (Cont.)
Aggregate lease payments for the right of use assets over the remaining lease period as of December 31, 2021 are as follows:
5,545
4,490
3,956
3,400
2,874
9,950
Total undiscounted lease payments
30,215
Less: adjustment to discounted lease payments
(2,765
Total discounted lease payments
27,450
The weighted average remaining lease terms and discount rates for all of operating leases were as follows as of December 31, 2021:
Weighted average remaining lease term (years):
7.37
Weighted average discount rate:
2.7
Total rent expenses for the years ended December 31, 2021, 2020 and 2019 were $6,193, $5,955 and $5,578, respectively (see also Note 17b).
NOTE 10:-OTHER PAYABLES AND ACCRUED EXPENSES
Accrued expenses and other
8,987
9,749
Subcontractors accrual
2,344
2,494
Accrued taxes
18,950
3,264
F - 32
NOTE 11:-COMMITMENTS AND CONTINGENT LIABILITIES
Litigation:
From time to time, the Company is party to other various legal proceedings, claims and litigation that arise in the normal course of business. It is the opinion of management that the ultimate outcome of these matters will not have a material adverse effect on the Company's financial position, results of operations or cash flows and believes that it had provided an adequate accrual to cover the costs to resolve such legal proceedings, demands and claims.
NOTE 12:-SHAREHOLDERS' EQUITY
The Company's shares are listed for trade on the NASDAQ Global Select Market under the symbol “RDWR”.
a.Rights of shares:
Ordinary Shares:
The ordinary shares confer upon the holders the right to receive notice to participate and vote in shareholders meetings of the Company and to receive dividend, if declared.
b.Treasury stock:
In March 2020, the Company's board of directors authorized a new plan for the repurchase of up to an aggregate of $20,000 of the Company’s ordinary shares in the open market, subject to normal trading restrictions, or in privately negotiated transactions.
In May 2020, the Company’s board of directors authorized a new plan for the repurchase of up to an aggregate of $56,800 of the Company’s ordinary shares in the open market, subject to normal trading restrictions, or in privately negotiated transactions.
In February 2022, the Company’s board of directors authorized a new plan for the repurchase of the Company’s ordinary shares in the open market (see Note 18).
c.Dividends:
Dividends, if any, will be paid in NIS. Dividends paid to shareholders outside Israel may be converted to U.S. dollars on the basis of the exchange rate prevailing at the date of the conversion. The Company does not intend to pay cash dividends in the foreseeable future.
F - 33
NOTE 12:- SHAREHOLDERS' EQUITY (Cont.)
d.Share Option Plans:
The Company has two stock option plans, the Company's Key Employee Share Incentive Plan (1997) as amended and restated (the “1997 Plan”) and the Directors and Consultants Option Plan (the “DC Plan” and together with the 1997 Plan, Stock Option Plans“). Under the Share Option Plans, options may be granted to officers, directors, employees and consultants of the Group. The exercise price per share under the Share Option Plans was generally not less than the market price of an ordinary share at the date of grant. The options vest primarily over four years. Each option is exercisable for one ordinary share. Any options, which are forfeited or not exercised before expiration, become available for future grants.
Pursuant to the Share Option Plans, the Company reserved for issuance 33,312,967 ordinary shares.
RSUs:
In addition to granting share options, since 2013, the Company started to routinely grant RSUs under the 1997 Plan. RSUs vest primarily over a four years period of employment. RSUs that are cancelled or forfeited become available for future grants.
The number of “Reserved and Authorized Shares” under the Equity Plans shall equal the sum of (i) the number of ordinary shares reserved and authorized under the Equity Incentive, and other awards granted under the Equity Incentive Plans as of such date, and (ii) the number of ordinary shares reserved.
As of December 31, 2021, the number of Reserved and Authorized Shares under the Equity Incentive Plans is as detailed below:
Share options exercised and outstanding
27,941,346
RSUs vested and outstanding
4,501,870
Ordinary shares available for issuance under the Equity Incentive Plans
869,751
Total reserved and authorized shares as of December 31, 2021
33,312,967
F - 34
A summary of employees and directors options activity under the Company's Stock Option Plans as of December 31, 2021 is as follows:
Number of options
Weighted-average
exercise price
Weighted- average
remaining contractual
term
(in years)
Aggregate intrinsic
Outstanding at January 1, 2021
3,637,050
21.97
3.41
21,021
Granted
252,233
32.18
Exercised
(798,116
17.50
Expired
(25,375
17.66
Forfeited
(915,480
23.63
Outstanding at December 31, 2021
2,150,312
24.17
3.39
37,566
Exercisable at December 31, 2021
651,141
22.13
2.28
12,703
Vested and expected to vest at December 31, 2021
2,022,211
24.12
3.35
35,420
The weighted-average grant-date fair value of options granted during the years ended December 31, 2021, 2020 and 2019 was $6.87, $4.74 and $5.54, respectively.
As of December 31, 2021, there was approximately $4,281 of total unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Company's stock option plans. That cost is expected to be recognized over a weighted-average period of 1.46 years.
The total intrinsic value of options exercised during the years 2021, 2020 and 2019 was $14,003, $13,335 and $13,720, respectively.
The aggregate intrinsic value of the outstanding stock options at December 31, 2021 and 2020, represents the intrinsic value of 2,150,312 and 3,637,050, respectively, outstanding options that are in-the-money as of such dates. No outstanding options were out-of-the-money as of December 31, 2021.
F - 35
The options outstanding under the Company's Stock Option Plans as of December 31, 2021, have been separated into ranges of exercise price as follows:
Outstanding
Exercisable
Ranges of
exercise
price
Number of
options
remaining
contractual
life (years)
Average
Exercise
13.35-17.63
195,170
0.76
16.89
20.26-24.89
1,363,349
3.76
23.16
291,808
23.13
25.25-29.10
396,585
2.55
26.79
164,163
26.59
32.71-35.43
195,208
5.09
33.20
The following table summarizes information relating to RSUs, as well as changes to such awards during 2021:
1,906,806
1,186,397
Vested
(558,071
(314,821
Outstanding as of December 31, 2021
2,220,311
As of December 31, 2021, there was approximately $44,774 of total unrecognized compensation costs related to non-vested RSUs granted under the Company's share option plans. That cost is expected to be recognized over a weighted-average period of 1.75 years.
The weighted-average grant date fair value of RSUs granted during the year ended December 31, 2021, 2020 and 2019 were $32.57, $22.54 and $23.41, respectively.
The weighted-average grant date fair value of RSUs vested during the year ended December 31, 2021, 2020 and 2019 were $21.77, $18.18 and $15.40, respectively.
The weighted-average grant date fair value of RSUs forfeited during the year ended December 31, 2021, 2020 and 2019 were $24.32, $23.24 and $19.40, respectively.
F - 36
Share-based compensation was recorded in the following items within the consolidated statements of income:
Cost of revenues
236
188
224
5,412
4,409
2,855
8,811
8,315
6,953
3,115
3,633
3,032
Total expenses
NOTE 13:-EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted net earnings per share:
Numerator for basic and diluted net earnings per share:
Weighted average shares outstanding, net of treasury stock:
Denominator for basic net earnings per share
Effect of dilutive securities:
Employee share options and RSUs
1,583,256
1,278,566
1,706,221
Denominator for diluted net earnings per share
F - 37
NOTE 14:-TAXES ON INCOME
a.General:
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
Beginning balance
7,125
5,597
Decrease related to settlement with tax authorities
(4,258
Additions for prior year tax positions
2,115
657
Decrease for prior year tax positions
(1,428
Additions for current year tax positions
1,758
871
Ending balance
5,312
As of December 31, 2021, the entire amount of the unrecognized tax benefits could affect the Company’s income tax provision and the effective tax rate.
The Company adjusts the unrecognized tax benefit liability and income tax expense in the period in which the uncertain tax position is effectively settled, the statute of limitations expires or when new information is available.
During the years ended December 31, 2021, 2020 and 2019 a net amounts of $243, $657 and $484, respectively, were added to the unrecognized tax benefits derived from interest and exchange rate differences expenses related to prior years’ uncertain tax positions. As of December 31, 2021, and 2020, the Company had accrued interest liability related to uncertain tax positions in the amounts of $97 and $698, respectively, which is included within other long-term liabilities on the consolidated balance sheets.
Exchange rate differences are recorded within financial income, net, while interest is recorded within taxes on income in the consolidated statements of income.
During November 2021, the Company reached a settlement with the Israeli Tax Authority (“ITA”) regarding the Company’s corporate tax returns for the years 2015-2018. As a result, the Company’s Israeli tax returns have been examined for all years including and prior to fiscal 2018, and the Company is no longer subject to audit for these periods. The settlement amounted to a total payment of $9,279 (NIS 28,858). The Company had provisions for the related years in the amount of $4,258 which were offset against such payment. In addition, as part of the settlement with the ITA, the Company received additional deductible expenses in the amount of $5,190.
The Company’s U.S subsidiary files income tax return in the U.S federal jurisdiction. As of December 31, 2021, the 2014 through 2020 tax years are open and may be subject to potential examinations in the U.S.
F - 38
NOTE 14:-TAXES ON INCOME (Cont.)
The Company believes that it has adequately provided for any reasonably foreseeable outcome related to tax audits and settlement. The final tax outcome of its tax audits could be different from that which is reflected in the Company’s income tax provisions and accruals. Such differences could have a material effect on the Company’s income tax provision and net income in the period in which such determination is made.
b.Israeli taxation:
1.Foreign Exchange Regulations:
Commencing taxable year 2003, the Company has elected to measure its taxable income and file its tax return under the Israeli Income Tax Regulations. Under the Foreign Exchange Regulations the Israeli company is calculating its tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into NIS according to the exchange rate as of December 31st of each year.
2.Tax rates:
The Israeli corporate tax rate in 2021, 2020 and 2019 was 23%. A company is taxable on its real capital gains at the corporate tax rate in the year of sale.
3.Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (“the Law“):
In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments (“Amendment 73“) was published. According to Amendment 73, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 and thereafter (the tax rate applicable to preferred enterprises located in other areas remains at 16%).
Amendment 73 also prescribes special tax tracks for technological enterprises, the new tax tracks under the amendment are as follows:
Technological preferred enterprise - an enterprise whose total consolidated revenues (parent company and all subsidiaries) is less than NIS 10 billion. Technological Preferred Enterprise, as defined in the law, which is located in the center of Israel (where our Israeli subsidiary is currently located) is subject to tax at a rate of 12% on profits deriving from intellectual property (in development area A, the tax rate is 7.5%), subject to satisfaction of a number of conditions, including compliance with a minimal amount or ratio of annual Research and development expenditure and Research and development employees, as well as having at least 25% of annual income derived from exports.
F - 39
The Company believes it meets the Technological preferred enterprise conditions.
Income not eligible for Preferred Technological Enterprise benefits is taxed at a regular rate, 23% from 2018 onwards.
Prior to 2014, most of the Company’s income was exempt from tax or subject to reduced tax rates under the Approved Enterprise program or the Beneficiary Enterprise in the Investment Law. Upon distribution of exempt income, the distributing company will be subject to corporate reduced tax rates ordinarily applicable to such income under the Investment Law.
Reduced income under the Investment Law including the Preferred Enterprise Regime and Preferred Technological Enterprise Regime will be freely distributable as dividends, subject to a 15% or 20% withholding tax (or lower rate for non-Israeli resident shareholder, under an applicable tax treaty).
On November 2, 2021, the Israeli Parliament approved a final bill regarding repatriations of trapped earnings out of Approved/Privileged Enterprises. The temporary provisions have come into effect as of November 15, 2021. The Israeli government agreed to grant relief on the amount of tax which should have been paid on distributable earnings in order to encourage companies to pay the reduced taxes during the next 12 months (the “temporary order”). The temporary order provides partial relief from previous Approved/Privileged Enterprise tax rates as defined in the Law for companies which opt to enjoy the privilege. The new temporary order does not require the actual distribution of the retained earnings, nor does it provides any relief from the 15% dividend withholding tax.
The partial relief from previous Approved/Privileged Enterprise tax rates is available to companies that elect to implement the temporary reduced tax relief by November 14, 2022, in respect of exempt retained earnings accrued up until December 31, 2021.
As part of the temporary order, the Company opted to implement the provisions included in the temporary order and completed the taxes on its trapped tax-exempt earnings. As a result, the Company has a tax payable amount as of December 31, 2021 of $8,247 included in other payables and accrued expenses in the consolidated balance sheets. As of December 31, 2021, the Company does not have any tax-exempted earnings attributable to its Beneficiary, Approved and Preferred Enterprise programs.
Through December 31, 2021, the Company has net operating carryforward losses of approximately $29,963 which can be carried forward and offset against taxable income in the future, for an indefinite period.
F - 40
c. Taxes on income are comprised as follows:
Current taxes
18,287
3,995
4,678
Deferred taxes
Domestic
10,741
2,648
1,833
Foreign
4,080
1,680
1,310
Domestic taxes:
12,890
3,166
3,670
(2,149
(518
(1,837
Foreign taxes:
5,397
829
1,008
(1,317
851
302
F - 41
d.Deferred income taxes:
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s and its subsidiaries’ deferred tax liabilities and assets are as follows:
Carryforward losses and tax credit
9,336
6,962
5,377
4,158
Unrealized gains on marketable securities
136
Temporary differences
6,583
6,071
Deferred tax assets before valuation allowance
21,432
17,191
Valuation allowance
(2,760
(1,992
Net deferred tax assets
18,672
15,199
Intangible assets, including goodwill
(4,543
(4,699
Depreciable assets
(1,699
(2,024
(453
(6,242
(7,176
12,430
8,023
e.Foreign:
On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018. Apportioned income is also subject to tax in various states.
Through December 31, 2021, the U.S. subsidiary had a U.S. federal loss carryforward of $4,448, which can be carried forward and offset against taxable income up to 20 years, expiring between fiscal 2023 and fiscal 2038.
Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.
F - 42
On March 27, 2020, President Donald J. Trump signed the Coronavirus Aid Relief, and Economic Security Act (the “CARES Act”) into law. The Act includes several significant business tax provisions that, among other things, eliminate the taxable income limit for certain net operating losses and allow businesses and individuals to carry back Net Operating Losses (“NOLs”) arising in 2018, 2019, and 2020 to the five prior tax years. Consequently, management intend is to carry back NOLs generated in 2019 and 2020 to tax years 2014 and 2015. The applicable tax rate during these years was 34%, therefore, recognizing a deferred benefit of $1,202 due to the remeasurement of the NOLs deferred tax asset.
The Company continues to monitor tax implications resulting from new legislation passed in response to the COVID-19 pandemic in the federal, state and foreign jurisdictions where it has an income tax expense.
f.Income taxes of non-Israeli subsidiaries:
Non-Israeli subsidiaries are taxed according to the tax laws in their respective countries of residence.
The Company does not provide deferred tax liabilities when it intends to reinvest earnings of foreign subsidiaries indefinitely.
F - 43
g.A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company and the actual tax expense as reported in the consolidated statements of income is as follows:
Income before taxes, as reported in the consolidated statements of income
Statutory tax rate
23
Theoretical tax expense (benefit) on the above amount at the Israeli statutory tax rate
5,205
3,212
5,913
Tax adjustment in respect of different tax rate of foreign subsidiary
33
(185
Non-deductible expenses and other permanent differences
305
83
Deferred taxes on losses for which valuation allowance was provided, net
896
959
592
Utilization of tax losses and deferred taxes for which valuation allowance was provided, net
(128
(152
(2,175
Foreign withholding taxes
2,656
1,489
Stock compensation relating to stock options per ASC No. 718
(2,369
1,258
821
Income taxes in respect of prior years
687
292
330
Change of tax rate
462
(599
Approved, Privileged and Preferred enterprise loss (benefits) (*)
6,869
(1,844
(2,783
205
257
Actual tax expense
(*)
Basic earnings per share amounts of the benefit resulting from the “Approved, Privileged and Preferred Enterprise” status
0.15
0.04
0.06
Diluted earnings per share amounts of the benefit resulting from the “Approved, Privileged and Preferred Enterprise” status
0.14
F - 44
h.Income before taxes on income is comprised as follows:
17,817
7,751
19,185
4,815
6,213
6,524
NOTE 15:-GEOGRAPHIC INFORMATION
Summary information about geographic areas:
The Company operates in one reportable segment (see Note 1 for a brief description of the Company's business). The total revenues are attributed to geographic areas based on the location of the end-users.
The following table presents total revenues for the years ended December 31, 2021, 2020 and 2019 from a geographical perspective:
Revenues from sales to customers located at:
The United States
98,937
93,706
85,447
America - other
29,833
20,707
20,982
EMEA*)
98,388
78,362
75,275
Asia Pacific
59,338
57,252
70,368
*) Europe, the Middle East and Africa.
F - 45
NOTE 15:- GEOGRAPHIC INFORMATION (Cont.)
The following table presents long-lived assets as of December 31, 2021 and 2020 from a geographical perspective:
Long-lived assets, by geographic region:
America (principally the United States)
2,609
3,592
39,467
43,711
EMEA - other
1,201
1,792
2,182
45,069
50,799
NOTE 16:-SELECTED CONSOLIDATED STATEMENTS OF INCOME DATA
Financial income, net:
Interest on bank deposits and other
4,131
5,916
7,016
Amortization of premiums, accretion of discounts and interest on debt marketable securities, net
1,855
3,700
3,639
438
639
537
Bank charges
(200
(189
(124
Foreign currency differences, net
(1,817
(2,270
(2,276
F - 46
NOTE 17:- BALANCES AND TRANSACTIONS WITH RELATED PARTIES
Represents transactions and balances with other entities in which certain members of the Company’s board of directors, management or shareholders have interest:
a.The following related party balances are included in the consolidated balance sheets:
Trade receivables and prepaid expenses
5,255
2,614
Trade payables and accrued expenses
476
b.The following related party transactions are included in the consolidated statements of income:
Revenues (1)
3,100
3,177
4,476
Cost of revenues (2)
11,482
7,061
Operating expenses, net - primarily lease, subcontractors and communications (3)
6,757
5,201
4,888
189
1,586
1,944
(1)Distribution of the Company’s products on a non-exclusive basis.
(2)Related to cost of product purchased from one of the related companies. The Group depended on a sole single managed security service provider, which is a related party, to provide services as part of its protection services. If the managed security service provider were to fail to provide or delay the delivery of the services, the Group would be required to seek alternative sources of the services. A change in its managed security service provider could result in a possible loss of sales and, consequently, could adversely affect the Group’s operation and financial performance (See Note 18a).
(3)The Company leases office space and purchases other miscellaneous services from certain companies, which are considered to be related parties. In addition, the Company provides certain services to related parties.
F - 47
NOTE 18:- SUBSEQUENT EVENTS
a.On February 17, 2022, the Company acquired all of the technology and other intangible assets from SecurityDam Ltd., which is a related company and the sole single-managed security service provider discussed in Note 1c and 17b(2) for a total consideration of (1) $30,000 in cash payable and (2) additional contingent consideration of up to $12,500 based on the performance of the Company’s cloud DDoS protection service after the acquisition.
b.In February 2022, the Company’s board of directors authorized a new plan for the repurchase of up to an aggregate of $80,000 of the Company’s ordinary shares in the open market, subject to normal trading restrictions, or in privately negotiated transactions.
- - - - - - - - - -
F - 48